CXT

Business Context and Reporting Period

Company: Crane Co. (Note: Input metadata referenced "Crane NXT, Co.", but the filing is for Crane Co.)
Filing Type: Form 8-K (Current Report)
Date of Report: October 22, 2012
Reporting Period: Quarter ended September 30, 2012
Primary Subject: Announcement of quarterly results of operations and detailed disclosure regarding asbestos liability claims and costs.

Key Financial Metrics

Note: This filing focuses on asbestos litigation costs rather than general operating revenue or profit. Specific revenue and net income figures are referenced in attached exhibits not included in the source text.

Asbestos Liability and Costs (Nine Months Ended Sept 30, 2012)

Asbestos Liability Balance Sheet Items

• Total Estimated Liability (Sept 30, 2012): $824 million (covers claims through 2021).
• Current Portion of Liability: $101 million (expected payments within 12 months).
• Estimated Insurance Recovery Asset (Sept 30, 2012): $216 million.
• Pending Claims (Sept 30, 2012): 56,773 total claims.

Material Changes vs. Prior Period

• Costs Incurred: Total asbestos costs incurred for the nine months ended Sept 30, 2012 ($73.5 million) decreased compared to the same period in 2011 ($82.9 million).
• Settlement Costs: Settlement/indemnity costs incurred dropped significantly from $42.1 million in 2011 to $29.3 million in 2012.
• Cash Payments: Net pre-tax cash payments increased slightly from $59.2 million in 2011 to $60.1 million in 2012, despite lower incurred costs, due to timing differences in payments and insurance receipts.
• Claim Volume: Ending pending claims decreased from 58,572 (Sept 30, 2011) to 56,773 (Sept 30, 2012), driven by higher dismissals (3,983 in 2012 vs. 10,539 in 2011) and lower new filings (2,720 in 2012 vs. 2,946 in 2011).

Outlook, Risks, and Management Commentary

Liability Estimate Methodology

Management, assisted by Hamilton, Rabinovitz & Associates (HR&A), updated its liability estimate in December 2011 to cover claims through 2021. As of September 30, 2012, management determined no change to the estimate was warranted. The estimate relies on four key factors: new mesothelioma claims, average settlement costs for mesothelioma, dismissal rates, and aggregate defense costs.

Significant Legal Developments

• California Supreme Court: Reversed a decision in the Patrick O'Neil case in favor of the Company, leading to a reversal of the Chief Brewer judgment in August 2012.
• Adverse Verdicts: Received an adverse verdict in the William Paulus case (Los Angeles) in August 2012; judgment requested is $0.8 million. The Company plans to appeal.
• Settlements/Dismissals: The James Nelson appeal remains pending. The Frank Paasch claim was dismissed with prejudice in May 2012.

Risks and Uncertainties

The filing highlights significant uncertainties regarding future claims, settlement costs, and insurance recoveries. While the Company believes it can reasonably estimate liability through 2021, it cannot estimate costs beyond that date. Factors such as legislative changes, case law trends, and the financial viability of insurers could materially alter the liability estimate.

Investor Verification Checklist

• Verify the specific revenue and net income figures for the quarter ended September 30, 2012, in the attached Exhibit 99.1 (Earnings Press Release) and Exhibit 99.2 (Financial Data Supplement), as they are not detailed in the 8-K text.
• Monitor the status of the pending James Nelson appeal and the William Paulus post-trial motions, as these could impact future liability estimates.
• Review the "coverage-in-place" agreements with excess insurers to understand the stability of the $216 million insurance recovery asset.
• Assess the impact of the 2021 forecast horizon; the Company explicitly states it cannot estimate liabilities beyond this date.
• Track the ratio of new mesothelioma claims versus dismissals, as these are the primary drivers of the liability model.